Tissue Factor-Induced Coagulation Can Be Inhibited by Aprotinin (Trasylol)

• References

• 1 Pintigny D, Dachary-Prigent J. A fluorescence and an enzymatic study. Aprotinin can inhibit the proteolytic activity of thrombin. Eur J Biochem 1992; 207: 89-95
• 2 Laurel MP, Ratnoff OD, Everson B. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol). J Lab Clin Med 1992; 119: 580-585
• 3 Van den Besselaar AMHP, Ram IE, Alderkamp GHJ, Bertina RM. The role of factor IX in tissue thromboplastin induced coagulation. Thromb Haemostas 1982; 48: 54-58
• 4 Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-Type inhibitor. Biochemistry 1990; 29: 7539-7546
• 5 Van Oeveren W, Van Oeveren B, Wildevuur ChRH. Anticoagulation policy during use of aprotinin in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 104: 210
• 6 Hunt BJ, Yacoub M. Aprotinin and cardiac surgery. Br Med J 1991; 303: 660-661
• 7 De Smet AAEA, Chang MNJ, Van Oeveren W. et al. Increased anticoagulation during cardiopulmonary bypass by aprotinin. J Thorac Cardiovasc Surg 1990; 100: 520-527